TELA Bio, Inc. (TELA) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by TELA Bio, Inc., a Delaware corporation, on October 31, 2025. The report discloses corporate governance changes regarding the Board of Directors.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the appointment of a new director and associated compensation arrangements.
Material Changes
- Board Expansion: The Board of Directors increased its size from six to seven members.
- New Appointment: William Plovanic was appointed as a Class I independent director, with a term expiring at the 2026 Annual Meeting of Stockholders.
- Compensation Structure:
- Initial Equity Award: Granted on October 31, 2025, consisting of an option to purchase 17,550 shares (vesting over 36 months) and 11,925 restricted stock units (vesting over three years).
- Annual Retainer: $45,000 per year for board service.
- Future Annual Awards: Starting at the 2026 Annual Meeting, Mr. Plovanic will receive an annual award of options for 11,700 shares and RSUs for 7,950 shares.
Outlook, Risks, and Management Commentary
The filing contains no forward-looking guidance, risk factors, or management commentary regarding the company's operational outlook. Mr. Plovanic brings significant experience in healthcare equity research and medical technology commercialization, having previously served as CEO and CFO of Obalon Therapeutics, Inc.
Key Facts for Investor Verification
- Verify the total number of shares authorized under the Amended and Restated 2019 Equity Incentive Plan to assess the impact of the new grants.
- Confirm the independence status of William Plovanic under Nasdaq listing rules as stated in the filing.
- Review the vesting schedules for the initial equity award to understand future dilution timelines.
- Check for any related party transactions involving Mr. Plovanic, though the filing explicitly states none exist.